U.S. markets open in 1 hour 2 minutes
  • S&P Futures

    3,803.75
    -38.75 (-1.01%)
     
  • Dow Futures

    30,559.00
    -283.00 (-0.92%)
     
  • Nasdaq Futures

    13,385.50
    -100.00 (-0.74%)
     
  • Russell 2000 Futures

    2,100.80
    -45.00 (-2.10%)
     
  • Crude Oil

    52.56
    -0.05 (-0.10%)
     
  • Gold

    1,839.10
    -11.80 (-0.64%)
     
  • Silver

    25.19
    -0.34 (-1.34%)
     
  • EUR/USD

    1.2118
    -0.0050 (-0.41%)
     
  • 10-Yr Bond

    1.0400
    0.0000 (0.00%)
     
  • Vix

    27.12
    +3.93 (+16.95%)
     
  • GBP/USD

    1.3702
    -0.0030 (-0.22%)
     
  • USD/JPY

    103.9050
    +0.2780 (+0.27%)
     
  • BTC-USD

    30,665.93
    -1,161.11 (-3.65%)
     
  • CMC Crypto 200

    617.55
    -22.37 (-3.50%)
     
  • FTSE 100

    6,564.81
    -89.20 (-1.34%)
     
  • Nikkei 225

    28,635.21
    +89.03 (+0.31%)
     

Benzinga's Top Upgrades, Downgrades For December 28, 2020

Benzinga Insights
·2 min read

 

Downgrades

  • Cantor Fitzgerald downgraded the previous rating for HMS Holdings Corp (NASDAQ:HMSY) from Overweight to Neutral. HMS Holdings earned $0.30 in the third quarter, compared to $0.24 in the year-ago quarter. The current stock performance of HMS Holdings shows a 52-week-high of $36.87 and a 52-week-low of $18.20. Moreover, at the end of the last trading period, the closing price was at $36.51.

 

Initiations

  • Morgan Stanley initiated coverage on PAE Inc (NASDAQ:PAE) with an Overweight rating. The price target for PAE is set to $11.00. Interestingly, in the third quarter, PAE's EPS was $0.11. The current stock performance of PAE shows a 52-week-high of $12.76 and a 52-week-low of $3.10. Moreover, at the end of the last trading period, the closing price was at $8.68.

  • BTIG initiated coverage on The RMR Group Inc (NASDAQ:RMR) with a Buy rating. The price target for RMR Group is set to $45.00. RMR Group earned $0.39 in the fourth quarter, compared to $0.59 in the year-ago quarter. The current stock performance of RMR Group shows a 52-week-high of $47.28 and a 52-week-low of $21.79. Moreover, at the end of the last trading period, the closing price was at $38.16.

  • SVB Leerink initiated coverage on Kinnate Biopharma Inc (NASDAQ:KNTE) with an Outperform rating. The price target for Kinnate Biopharma is set to $52.00. The current stock performance of Kinnate Biopharma shows a 52-week-high of $48.75 and a 52-week-low of $34.14. Moreover, at the end of the last trading period, the closing price was at $38.00.

  • Piper Sandler initiated coverage on Kinnate Biopharma Inc (NASDAQ:KNTE) with an Overweight rating. The price target for Kinnate Biopharma is set to $60.00. At the moment, the stock has a 52-week-high of $48.75 and a 52-week-low of $34.14. Kinnate Biopharma closed at $38.00 at the end of the last trading period.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.